龙沙集团投资大规模生物制造、生物偶联及药品生产领域——DCAT价值链洞察
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
生物技术与制药领域的最新动态
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
Lonza Implements Streamlined Operating Model - Contract Pharma
Lonza Leadership Visits UNH's Tissue Culture Lab - University of New Hampshire
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess International
Lonza Partners with UNH to Offer Life Sciences Scholarship and Mentorship Program | UNH Today - University of New Hampshire
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology